Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Ethics 2006;32:542-547; doi:10.1136/jme.2005.014670
Copyright © 2006 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.

RESEARCH ETHICS

Trust based obligations of the state and physician-researchers to patient-subjects

P B Miller1 and C Weijer2

1 Department of Philosophy, University of Toronto, Toronto, Ontario, Canada
2 Department of Philosophy, Talbot College, University of Western Ontario, London, Ontario, Canada

Correspondence to:
Correspondence to:
C Weijer
Department of Philosophy, Talbot College, University of Western Ontario, London, ON N6A 3K7, Canada; cweijer{at}uwo.ca

When may a physician enroll a patient in clinical research? An adequate answer to this question requires clarification of trust-based obligations of the state and the physician-researcher respectively to the patient-subject. The state relies on the voluntarism of patient-subjects to advance the public interest in science. Accordingly, it is obligated to protect the agent-neutral interests of patient-subjects through promulgating standards that secure these interests. Component analysis is the only comprehensive and systematic specification of regulatory standards for benefit-harm evaluation by research ethics committees (RECs). Clinical equipoise, a standard in component analysis, ensures the treatment arms of a randomised control trial are consistent with competent medical care. It thus serves to protect agent-neutral welfare interests of the patient-subject. But REC review occurs prior to enrolment, highlighting the independent responsibility of the physician-researcher to protect the agent-relative welfare interests of the patient-subject. In a novel interpretation of the duty of care, we argue for a "clinical judgment principle" which requires the physician-researcher to exercise judgment in the interests of the patient-subject taking into account evidence on treatments and the patient-subject‘s circumstances.

Abbreviations: RCT, randomised controlled trial; REC, research ethics committee


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • de Melo-Martin, I, Ho, A (2008). Beyond informed consent: the therapeutic misconception and trust. J. Med. Ethics 34: 202-205 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.